MM-151 drug page Clinical trials

Trials with MM-151

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
1Countries
117Planned patients

Showing 1–2 of 2

Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
Finished Phase 1 5 patients NCT02538627

This is a Phase 1 open-label, dose-escalation trial using "3+3" design, evaluating MM-151 co-administration with MM-121, MM-141, and trametinib at varying dose levels.

United States Aug 2015 – Oct 2016 Interventional
Combined with: MM-121MM-141Trametinib
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Finished Phase 1 112 patients NCT01520389

This study is a Phase 1 and pharmacologic open-labeled dose-escalation trial using a "3+3" design, evaluating MM-151 at varying dose levels and frequencies, and subsequently in combination with irinotecan.

United States Jan 2012 – Jan 2016 Interventional
Combined with: Irinotecan